Changes in cognitive function in patients with diabetes mellitus;A kognitív funkciók változásai cukorbetegségben

Orvosi Hetilap

Volumn 153, Issue 9, 2012, Pages 323-329

  Szémán, Barbara ^a   Nagy, Géza ^a   Varga, Tímea ^a   Veres Székely, Anna ^b   Sasvári, Mária ^a   Fitala, Dávid ^a   Szöllosi, Adrienn ^a   Katonai, Rózsa ^b   Kotyuk, Eszter ^b   Somogyi, Anikó ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Cognitive; Diabetes; Functions; Hippocampus; Mellitus

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

AMNESIA; ARTICLE; ATTENTION; BRAIN ATROPHY; CENTRAL NERVOUS SYSTEM; COGNITION; COGNITIVE DEFECT; DIABETES MELLITUS; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FRONTAL LOBE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERINSULINISM; HYPOGLYCEMIA; INFORMATION PROCESSING; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LEUKOARAIOSIS; MENTAL FUNCTION; MICROANGIOPATHY; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PATHOPHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; VISION;

AGE OF ONSET; ANIMALS; ATTENTION; BRAIN; COGNITION; COGNITION DISORDERS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FRONTAL LOBE; HIGHER NERVOUS ACTIVITY; HIPPOCAMPUS; HUMANS; LEUKOARAIOSIS; MEMORY DISORDERS; PSYCHOMOTOR PERFORMANCE; THINKING;

EID: 84857604015     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2012.29319     Document Type: Article

References (39)

1. Wild, S., Roglic, G., Green, A., et al.: Global prevalence of diabetes: estimates for the year 20 00 and projections for 2030. Diabetes Care, 2004, 27, 1047-1053. (Pubitemid 38579764)
2. Zhao, Y., Ye, W., Boye, K. S., et al.: Prevalence of other diabetesassociated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy. J. Diabetes Complications, 2010, 24, 9-19.
3. Gispen, W. H., Biessels, G. J.: Cognition and synaptic plasticity in diabetes mellitus. Trends Ne urosci, 2000, 23, 542-549.
4. Elias, M. F., Elias, P. K., Sullivan, L. M., et al.: Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiol. Aging, 2005, 26 (Suppl 1), 11-16.
5. Jimenez-Bonilla, J. F., Quirce, R., Hernandez, A., et al.: Assessment of cerebral perfusion and c erebrovascular reserve in insulindependent diabetic patients without central neurological symptoms by means of 99mTc-HMPAO SPET with acetazolamide. Eur. J. Nucl. Med., 2001, 28, 1647-1655. (Pubitemid 33036107)
6. Boyle, P. J., Nagy, R. J., O'Connor, A. M., et al.: Adaptation in brain glucose uptake following recurrent hypoglycemia. Proc. Natl. Acad. Sci. USA, 1994, 91, 9352-9356. (Pubitemid 24297912)
7. Magarinos, A. M., McEwen, B. S.: Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc. Natl. Acad. Sci. USA, 2000, 97, 11056-11061.
8. Saravia, F. E., Revsin, Y., Gonzalez Deniselle, M. C., et al.: Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin- treated mice. Brain Res., 2002, 957, 345-353. (Pubitemid 35356530)
9. Hall, J. L., Gonder-Frederick, L. A., Chewning, W. W., et al.: Glucose enhancement of performance on memory tests in young and aged humans. Neuropsychologia, 1989, 27, 1129-1138. (Pubitemid 19256781)
10. Craft, S., Asthana, S., Newcomer, J. W., et al.: Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch. Gen. Psychiatry, 1999, 56, 1135-1140.
11. Biessels, G. J., van der Heide, L. P., Kamal, A., et al.: Ageing and diabetes: implications for brain function. Eur. J. Pharmacol., 2002, 441, 1-14. (Pubitemid 34465684)
12. Arvanitakis, Z., Wilson, R. S., Bienias, J. L., et al.: Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch. Neurol., 2004, 61, 661-666. (Pubitemid 38637681)
13. Chan, R. C., Shum, D., Toulopoulou, T., et al.: Assessment of executive functions: review of instruments and identification of critical issues. Arch. Clin. Neuropsychol., 2008, 23, 201-216.
14. Christou, C., Bulthoff, H. H.: Perception, representation and recognition: a holistic view of re cognition. Spat. Vis., 2000, 13, 265-275. (Pubitemid 32088066)
15. Ott, A., Stolk, R. P., van Harskamp, F., et al.: Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology, 1999, 53, 1937-1942.
16. Brands, A. M., Biessels, G. J., de Haan, E. H., et al.: The effects of type 1 diabetes on cognit ive performance: a meta-analysis. Diabetes Care, 2005, 28, 726-735. (Pubitemid 40315341)
17. Convit, A.: Links between cognitive impairment in insulin resistance: an explanatory model. Neur obiol. Aging, 2005, 26 (Suppl 1), 31-35.
18. Brands, A. M., Biessels, G. J., Kappelle, L. J., et al.: Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study. Dement Geriatr. Cogn. Disord., 2007, 23, 343-350. (Pubitemid 46631942)
19. Biessels, G. J., Deary, I. J., Ryan, C. M.: Cognition and diabetes: a lifespan perspective. Lanc et Neurol., 2008, 7, 184-190.
20. Biessels, G. J., Kappelle, L. J., Utrecht Diabetic Encephalopathy Study Group: Increased risk of Alzheimer's disease in type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem. Soc. Trans., 2005, 33, 1041-1044. (Pubitemid 41659109)
21. Kumari, M., Brunner, E., Fuhrer, R.: Minireview: mechanisms by which the metabolic syndrome and diabetes impair memory. J. Gerontol. A. Biol. Sci. Med. Sci., 2000, 55, B228-232. (Pubitemid 30314068)
22. Brands, A. M., Kessels, R. P., Hoogma, R. P., et al.: Cognitive performance, psychological well- being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes, 2006, 55, 1800-1806. (Pubitemid 44324135)
23. Weinger, K., Jacobson, A. M., Musen, G., et al.: The effects of type 1 diabetes on cerebral white matter. Diabetologia, 2008, 51, 417-425.
24. Biessels, G.-J., ter Braak, E. W. M. T., Erkelens, D. W., et al.: Cognitive function in patients with type 2 diabetes mellitus. Neuroscience Research Communications, 2001, 28, 11-22. (Pubitemid 32194789)
25. Widom, B., Simonson, D. C.: Glycemic control and neuropsychologic function during hypoglycemia i n patients with insulin-dependent diabetes mellitus. Ann. Intern. Med., 1990, 112, 904-912. (Pubitemid 20193674)
26. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group: Long-term effect of diabetes and its treatment on cognitive function. N. Engl. J. Med., 2007, 356, 1842-1852.
27. Aszalos, Z.: Cerebral complications of diabetes mellitus. [A diabetes mellitus agyi szövodményei.] Orv. Hetil., 2007, 148, 2371-2376.
28. Smith, M. A., Sayre, L. M., Monnier, V. M., et al.: Radical AGEing in Alzheimer's disease. Trends Neurosci., 1995, 18, 172-176.
29. Akisaki, T., Sakurai, T., Takata, T., et al.: Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab. Res. Rev., 2006, 22, 376-384. (Pubitemid 44446433)
30. Jellinger, K. A.: The pathology of "vascular dementia": a critical update. J. Alzheimers Dis., 2 008, 14, 107-123. (Pubitemid 352039011)
31. Cole, G. M., Frautschy, S. A.: The role of insulin and neuro trophic factor signaling in brain ag ing and Alzheimer's disease. Exp. Gerontol., 2007, 42, 10-21. (Pubitemid 44937832)
32. Grossman, H.: Does diabetes protect or provoke Alzheimer's disease? Insights into the pathobiolo gy and future treatment of Alzheimer's disease. CNS Spectr., 2003, 8, 815-823.
33. Messier, C.: Diabetes, Alzheimer's disease and apolipoprotein genotype. Exp. Gerontol., 2003, 38 , 941-946. (Pubitemid 37040796)
34. Starr, V. L., Convit, A.: Diabetes, sugar-coated but harmful to the brain. Curr. Opin. Pharmacol ., 2007, 7, 638-642. (Pubitemid 350185857)
35. Kamal, A., Biessels, G. J., Gispen, W. H., et al.: Synaptic transmission changes in the pyramida l cells of the hippocampus in streptozotocin- induced diabetes mellitus in rats. Brain Res., 2006, 1073-1074, 276-280.
36. Biessels, G. J., Kamal, A., Urban, I. J., et al.: Water maze learning and hippocampal synaptic p lasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Res., 1998, 800, 125-135. (Pubitemid 28361929)
37. Gold, S. M., Dziobek, I., Sweat, V., et al.: Hippocampal damage and memory impairments as possib le early brain complications of type 2 diabetes. Diabetologia, 2007, 50, 711-719. (Pubitemid 46355836)
38. Winocur, G., Greenwood, C. E., Piroli, G. G., et al.: Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity. Behav. Neurosci., 2005, 119, 1389-1395. (Pubitemid 41598751)
39. Musen, G., Lyoo, I. K., Sparks, C. R., et al.: Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes, 2006, 55, 326-333. (Pubitemid 43343260)